25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

HURA (TuHURA Biosciences Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze TuHURA Biosciences Inc together

I guess you are interested in TuHURA Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – TuHURA Biosciences Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – TuHURA Biosciences Inc’s Price Targets

I'm going to help you getting a better view of TuHURA Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about TuHURA Biosciences Inc

I send you an email if I find something interesting about TuHURA Biosciences Inc.

1. Quick Overview

1.1. Quick analysis of TuHURA Biosciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of TuHURA Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
87.9%

What is your share worth?

Current worth
$0.23
Expected worth in 1 year
$0.71
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$0.49
Return On Investment
21.1%

For what price can you sell your share?

Current Price per Share
$2.30
Expected price per share
$1.8 - $3.43
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of TuHURA Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)
$2.30
Intrinsic Value Per Share
$-2.42 - $-2.78
Total Value Per Share
$-2.19 - $-2.55

2.2. Growth of TuHURA Biosciences Inc (5 min.)




Is TuHURA Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$9.8m-$1.8m$10.5m121.6%

How much money is TuHURA Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$4.2m-$2.3m-$1.9m-45.5%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of TuHURA Biosciences Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of TuHURA Biosciences Inc?

Welcome investor! TuHURA Biosciences Inc's management wants to use your money to grow the business. In return you get a share of TuHURA Biosciences Inc.

First you should know what it really means to hold a share of TuHURA Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of TuHURA Biosciences Inc is $2.3. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of TuHURA Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in TuHURA Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.23. Based on the TTM, the Book Value Change Per Share is $0.12 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of TuHURA Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.15-6.6%-0.10-4.2%-0.05-2.3%-0.11-4.9%-0.14-6.0%-0.10-4.2%
Usd Book Value Change Per Share-0.11-4.7%0.125.3%-0.08-3.3%-0.01-0.4%0.010.3%0.010.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.11-4.7%0.125.3%-0.08-3.3%-0.01-0.4%0.010.3%0.010.3%
Usd Price Per Share3.23-2.51-2.09-2.42-1.97-1.79-
Price to Earnings Ratio-5.29--131.47--2,432.65--922.70--564.67--311.89-
Price-to-Total Gains Ratio-29.79--4.95--22.04-5.62--1.80--6.59-
Price to Book Ratio14.31-10.53-26.92-18.90-19.21-21.82-
Price-to-Total Gains Ratio-29.79--4.95--22.04-5.62--1.80--6.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.3
Number of shares434
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.120.01
Usd Total Gains Per Share0.120.01
Gains per Quarter (434 shares)52.743.40
Gains per Year (434 shares)210.9713.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102112010144
2042241202718
3063362304132
4084483405446
501055104506860
601266125608174
701477146709588
80168816780108102
90189818891122116
100210921001135130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%0.011.00.00.0%0.018.00.00.0%0.033.00.00.0%0.033.00.00.0%
Book Value Change Per Share2.01.00.066.7%4.07.00.036.4%6.012.00.033.3%11.022.00.033.3%11.022.00.033.3%
Dividend per Share1.00.02.033.3%7.00.04.063.6%14.00.04.077.8%29.00.04.087.9%29.00.04.087.9%
Total Gains per Share2.01.00.066.7%4.07.00.036.4%6.012.00.033.3%11.022.00.033.3%11.022.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of TuHURA Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1080.122-189%-0.076-30%-0.009-92%0.008-1490%0.007-1686%
Book Value Per Share--0.2260.200+13%-0.043+119%0.112+102%0.194+17%0.159+42%
Current Ratio--2.9962.439+23%0.756+296%1.991+50%3.383-11%4.130-27%
Debt To Asset Ratio--0.3270.395-17%1.581-79%0.790-59%0.587-44%0.440-26%
Debt To Equity Ratio--0.4850.765-37%1.111-56%0.766-37%1.097-56%0.784-38%
Dividend Per Share--0.0000.000+200%0.000+39%0.000+63%0.000+33%0.000+16%
Enterprise Value--136305478.000112443321.667+21%87671936.900+55%107200302.236+27%91248941.267+49%83275912.455+64%
Eps---0.153-0.097-37%-0.053-65%-0.113-26%-0.137-10%-0.098-36%
Free Cash Flow Per Share---0.109-0.071-35%-0.057-48%-0.077-29%-0.088-20%-0.075-31%
Free Cash Flow To Equity Per Share---0.122-0.102-16%-0.002-98%-0.048-61%-0.017-86%-0.017-86%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---2.775----------
Intrinsic Value_10Y_min---2.416----------
Intrinsic Value_1Y_max---0.305----------
Intrinsic Value_1Y_min---0.300----------
Intrinsic Value_3Y_max---0.896----------
Intrinsic Value_3Y_min---0.856----------
Intrinsic Value_5Y_max---1.462----------
Intrinsic Value_5Y_min---1.359----------
Market Cap100464920.000-40%141087692.000109419402.000+29%91117314.400+55%105881289.600+33%85933906.933+64%78340135.576+80%
Net Profit Margin----0%-0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%-0%
Pb Ratio10.193-40%14.31410.527+36%26.920-47%18.901-24%19.215-26%21.819-34%
Pe Ratio-3.769+29%-5.293-131.473+2384%-2432.648+45863%-922.697+17334%-564.670+10569%-311.888+5793%
Price Per Share2.300-40%3.2302.505+29%2.086+55%2.424+33%1.967+64%1.793+80%
Price To Free Cash Flow Ratio-5.253+29%-7.377-8.515+15%-7.587+3%-9.402+27%-6.942-6%-6.666-10%
Price To Total Gains Ratio-21.216+29%-29.794-4.949-83%-22.041-26%5.624-630%-1.805-94%-6.593-78%
Quick Ratio---1.757-100%0.490-100%1.518-100%2.994-100%3.743-100%
Return On Assets---0.455-0.252-45%-0.555+22%-0.528+16%-0.537+18%-0.476+5%
Return On Equity---0.676-0.363-46%-1.141+69%-0.884+31%-1.516+124%-1.106+64%
Total Gains Per Share---0.1080.122-189%-0.076-30%-0.009-92%0.008-1483%0.007-1676%
Usd Book Value--9856463.0008715146.333+13%-1881320.750+119%4890528.182+102%8453445.778+17%6925363.939+42%
Usd Book Value Change Per Share---0.1080.122-189%-0.076-30%-0.009-92%0.008-1490%0.007-1686%
Usd Book Value Per Share--0.2260.200+13%-0.043+119%0.112+102%0.194+17%0.159+42%
Usd Dividend Per Share--0.0000.000+200%0.000+39%0.000+63%0.000+33%0.000+16%
Usd Enterprise Value--136305478.000112443321.667+21%87671936.900+55%107200302.236+27%91248941.267+49%83275912.455+64%
Usd Eps---0.153-0.097-37%-0.053-65%-0.113-26%-0.137-10%-0.098-36%
Usd Free Cash Flow---4781094.000-3097038.000-35%-1869811.250-61%-3068831.545-36%-3632279.833-24%-3184231.485-33%
Usd Free Cash Flow Per Share---0.109-0.071-35%-0.057-48%-0.077-29%-0.088-20%-0.075-31%
Usd Free Cash Flow To Equity Per Share---0.122-0.102-16%-0.002-98%-0.048-61%-0.017-86%-0.017-86%
Usd Market Cap100464920.000-40%141087692.000109419402.000+29%91117314.400+55%105881289.600+33%85933906.933+64%78340135.576+80%
Usd Price Per Share2.300-40%3.2302.505+29%2.086+55%2.424+33%1.967+64%1.793+80%
Usd Profit---6664371.000-4221920.373-37%-2301170.745-65%-4915943.282-26%-6003077.117-10%-4261411.791-36%
Usd Revenue----0%-0%-0%-0%-0%
Usd Total Gains Per Share---0.1080.122-189%-0.076-30%-0.009-92%0.008-1483%0.007-1676%
 EOD+3 -5MRQTTM+13 -20YOY+16 -173Y+16 -175Y+16 -1710Y+16 -17

3.3 Fundamental Score

Let's check the fundamental score of TuHURA Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.769
Price to Book Ratio (EOD)Between0-110.193
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than12.996
Debt to Asset Ratio (MRQ)Less than10.327
Debt to Equity Ratio (MRQ)Less than10.485
Return on Equity (MRQ)Greater than0.15-0.676
Return on Assets (MRQ)Greater than0.05-0.455
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of TuHURA Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.213
Ma 20Greater thanMa 502.448
Ma 50Greater thanMa 1003.027
Ma 100Greater thanMa 2003.140
OpenGreater thanClose2.520
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About TuHURA Biosciences Inc

TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda; and Delta receptor technology to develop tumor microenvironment modulators in the form of first-in-class bi-specific antibody-peptide conjugates and antibody-drug conjugates targeting Myeloid Derived Suppressor Cells. In addition, the company is also developing Immune Fx; IFx-3.0, an mRNA innate immune agonist candidate for intravenous or autologous whole cell administration for blood-related cancers. The company was formerly known as Morphogenesis, Inc. and changed its name to TuHURA Biosciences, Inc. in December 2023. The company was founded in 1995 and is based in Tampa, Florida. TuHURA Biosciences, Inc. operates as a subsidiary of CohBar, Inc.

Fundamental data was last updated by Penke on 2025-06-29 15:21:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ TuHURA Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ TuHURA Biosciences Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of TuHURA Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--93.6%+93.6%
TTM--140.9%+140.9%
YOY--197.6%+197.6%
3Y--248.5%+248.5%
5Y--343.4%+343.4%
10Y--496.2%+496.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ TuHURA Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ TuHURA Biosciences Inc to theΒ Biotechnology industry mean.
  • -45.5% Return on Assets means thatΒ TuHURA Biosciences Inc generatedΒ $-0.46 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of TuHURA Biosciences Inc:

  • The MRQ is -45.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -25.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-45.5%TTM-25.2%-20.3%
TTM-25.2%YOY-55.5%+30.3%
TTM-25.2%5Y-53.7%+28.5%
5Y-53.7%10Y-47.6%-6.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.5%-11.6%-33.9%
TTM-25.2%-11.6%-13.6%
YOY-55.5%-11.4%-44.1%
3Y-52.8%-11.8%-41.0%
5Y-53.7%-12.0%-41.7%
10Y-47.6%-13.7%-33.9%
4.3.1.3. Return on Equity

Shows how efficient TuHURA Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ TuHURA Biosciences Inc to theΒ Biotechnology industry mean.
  • -67.6% Return on Equity means TuHURA Biosciences Inc generated $-0.68Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of TuHURA Biosciences Inc:

  • The MRQ is -67.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -36.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-67.6%TTM-36.3%-31.3%
TTM-36.3%YOY-114.1%+77.7%
TTM-36.3%5Y-151.6%+115.2%
5Y-151.6%10Y-110.6%-40.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-67.6%-13.5%-54.1%
TTM-36.3%-14.9%-21.4%
YOY-114.1%-14.6%-99.5%
3Y-88.4%-16.8%-71.6%
5Y-151.6%-17.5%-134.1%
10Y-110.6%-19.9%-90.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of TuHURA Biosciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient TuHURA Biosciences Inc is operatingΒ .

  • Measures how much profit TuHURA Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ TuHURA Biosciences Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of TuHURA Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.5%+232.5%
TTM--250.5%+250.5%
YOY--209.2%+209.2%
3Y--234.1%+234.1%
5Y--346.1%+346.1%
10Y--477.5%+477.5%
4.3.2.2. Operating Ratio

Measures how efficient TuHURA Biosciences Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of TuHURA Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.111-2.111
TTM-2.694-2.694
YOY-3.096-3.096
3Y-3.652-3.652
5Y-4.745-4.745
10Y-6.614-6.614
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of TuHURA Biosciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if TuHURA Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 3.00Β means the company has $3.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of TuHURA Biosciences Inc:

  • The MRQ is 2.996. The company is able to pay all its short-term debts. +1
  • The TTM is 2.439. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.996TTM2.439+0.557
TTM2.439YOY0.756+1.683
TTM2.4395Y3.383-0.944
5Y3.38310Y4.130-0.747
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9963.661-0.665
TTM2.4393.846-1.407
YOY0.7564.140-3.384
3Y1.9914.688-2.697
5Y3.3835.746-2.363
10Y4.1306.147-2.017
4.4.3.2. Quick Ratio

Measures if TuHURA Biosciences Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ TuHURA Biosciences Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.00Β means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of TuHURA Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.757-1.757
TTM1.757YOY0.490+1.266
TTM1.7575Y2.994-1.237
5Y2.99410Y3.743-0.749
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.848-2.848
TTM1.7573.169-1.412
YOY0.4903.786-3.296
3Y1.5184.311-2.793
5Y2.9945.703-2.709
10Y3.7436.368-2.625
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of TuHURA Biosciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of TuHURA Biosciences IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ TuHURA Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.33Β means that TuHURA Biosciences Inc assets areΒ financed with 32.7% credit (debt) and the remaining percentage (100% - 32.7%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of TuHURA Biosciences Inc:

  • The MRQ is 0.327. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.395. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.327TTM0.395-0.069
TTM0.395YOY1.581-1.185
TTM0.3955Y0.587-0.191
5Y0.58710Y0.440+0.147
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3270.329-0.002
TTM0.3950.349+0.046
YOY1.5810.331+1.250
3Y0.7900.340+0.450
5Y0.5870.349+0.238
10Y0.4400.379+0.061
4.5.4.2. Debt to Equity Ratio

Measures ifΒ TuHURA Biosciences Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ TuHURA Biosciences Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 48.5% means that company has $0.49 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of TuHURA Biosciences Inc:

  • The MRQ is 0.485. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.765. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.485TTM0.765-0.280
TTM0.765YOY1.111-0.346
TTM0.7655Y1.097-0.332
5Y1.09710Y0.784+0.313
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4850.379+0.106
TTM0.7650.437+0.328
YOY1.1110.414+0.697
3Y0.7660.450+0.316
5Y1.0970.464+0.633
10Y0.7840.515+0.269
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings TuHURA Biosciences Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ TuHURA Biosciences Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -5.29 means the investor is paying $-5.29Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of TuHURA Biosciences Inc:

  • The EOD is -3.769. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.293. Based on the earnings, the company is expensive. -2
  • The TTM is -131.473. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.769MRQ-5.293+1.524
MRQ-5.293TTM-131.473+126.180
TTM-131.473YOY-2,432.648+2,301.176
TTM-131.4735Y-564.670+433.198
5Y-564.67010Y-311.888-252.783
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.769-2.356-1.413
MRQ-5.293-2.077-3.216
TTM-131.473-2.574-128.899
YOY-2,432.648-3.760-2,428.888
3Y-922.697-3.773-918.924
5Y-564.670-6.193-558.477
10Y-311.888-6.876-305.012
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of TuHURA Biosciences Inc:

  • The EOD is -5.253. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.377. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.515. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.253MRQ-7.377+2.124
MRQ-7.377TTM-8.515+1.138
TTM-8.515YOY-7.587-0.928
TTM-8.5155Y-6.942-1.573
5Y-6.94210Y-6.666-0.276
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.253-3.246-2.007
MRQ-7.377-2.705-4.672
TTM-8.515-3.704-4.811
YOY-7.587-4.402-3.185
3Y-9.402-5.070-4.332
5Y-6.942-8.477+1.535
10Y-6.666-9.305+2.639
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ TuHURA Biosciences Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 14.31 means the investor is paying $14.31Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of TuHURA Biosciences Inc:

  • The EOD is 10.193. Based on the equity, the company is expensive. -2
  • The MRQ is 14.314. Based on the equity, the company is expensive. -2
  • The TTM is 10.527. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD10.193MRQ14.314-4.121
MRQ14.314TTM10.527+3.787
TTM10.527YOY26.920-16.393
TTM10.5275Y19.215-8.688
5Y19.21510Y21.819-2.604
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD10.1932.038+8.155
MRQ14.3141.843+12.471
TTM10.5272.125+8.402
YOY26.9202.442+24.478
3Y18.9012.492+16.409
5Y19.2153.652+15.563
10Y21.8194.311+17.508
4.6.2. Total Gains per Share

2.4. Latest News of TuHURA Biosciences Inc

Does TuHURA Biosciences Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from TuHURA Biosciences Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-23
23:19
TuHURA Biosciences and Kineta stockholders approve proposed dealRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets14,639
Total Liabilities4,782
Total Stockholder Equity9,856
 As reported
Total Liabilities 4,782
Total Stockholder Equity+ 9,856
Total Assets = 14,639

Assets

Total Assets14,639
Total Current Assets14,325
Long-term Assets313
Total Current Assets
Cash And Cash Equivalents 6,220
Other Current Assets 487
Total Current Assets  (as reported)14,325
Total Current Assets  (calculated)6,707
+/- 7,618
Long-term Assets
Property Plant Equipment 313
Long-term Assets  (as reported)313
Long-term Assets  (calculated)313
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,782
Long-term Liabilities0
Total Stockholder Equity9,856
Total Current Liabilities
Accounts payable 3,084
Total Current Liabilities  (as reported)4,782
Total Current Liabilities  (calculated)3,084
+/- 1,698
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)9,856
Total Stockholder Equity (calculated)0
+/- 9,856
Other
Capital Stock322
Common Stock Shares Outstanding 43,680
Net Invested Capital 9,578
Net Working Capital 9,543
Property Plant and Equipment Gross 2,415



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
> Total Assets 
5,047
3,594
2,341
7,911
14,448
12,216
9,677
7,075
4,750
4,038
2,457
4,037
8,364
6,508
5,102
2,938
23,131
20,489
18,853
13,543
22,343
17,718
12,798
15,948
13,210
9,917
10,440
3,979
1,477
1,885
5,786
6,202
4,140
19,967
14,639
14,63919,9674,1406,2025,7861,8851,4773,97910,4409,91713,21015,94812,79817,71822,34313,54318,85320,48923,1312,9385,1026,5088,3644,0372,4574,0384,7507,0759,67712,21614,4487,9112,3413,5945,047
   > Total Current Assets 
5,015
3,566
2,291
7,871
14,413
12,187
9,642
7,046
4,728
4,020
2,401
4,025
8,354
6,502
5,099
2,757
22,955
17,717
16,588
11,793
20,108
14,998
10,093
13,258
8,156
9,178
10,111
3,270
783
1,186
5,297
5,528
3,483
19,610
14,325
14,32519,6103,4835,5285,2971,1867833,27010,1119,1788,15613,25810,09314,99820,10811,79316,58817,71722,9552,7575,0996,5028,3544,0252,4014,0204,7287,0469,64212,18714,4137,8712,2913,5665,015
       Cash And Cash Equivalents 
4,799
3,417
2,100
6,586
13,156
11,022
8,507
5,972
3,885
3,703
2,152
3,719
8,060
6,348
4,973
2,392
22,602
17,158
15,718
10,537
19,339
14,064
8,839
11,780
7,085
4,874
9,820
1,535
216
658
4,461
4,909
3,020
12,657
6,220
6,22012,6573,0204,9094,4616582161,5359,8204,8747,08511,7808,83914,06419,33910,53715,71817,15822,6022,3924,9736,3488,0603,7192,1523,7033,8855,9728,50711,02213,1566,5862,1003,4174,799
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,995
0
05,995000000000000000000000000000000000
       Net Receivables 
38
18
71
77
41
25
62
40
12
10
9
26
71
31
10
9
10
8
7
0
0
0
0
0
0
0
0
0
0
103
334
0
258
223
0
0223258033410300000000007810910317126910124062254177711838
       Other Current Assets 
177
131
120
1,208
1,216
1,141
1,073
1,035
831
307
240
280
224
123
115
356
343
551
863
1,256
769
934
1,254
1,478
1,071
4,304
291
1,735
567
425
501
619
0
736
487
48773606195014255671,7352914,3041,0711,4781,2549347691,2568635513433561151232242802403078311,0351,0731,1411,2161,208120131177
   > Long-term Assets 
32
28
50
40
35
29
35
28
22
18
56
12
9
6
4
181
176
2,772
2,265
1,750
2,235
2,720
2,705
2,690
5,054
739
330
709
694
699
489
674
657
356
313
3133566576744896996947093307395,0542,6902,7052,7202,2351,7502,2652,772176181469125618222835293540502832
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
175
172
165
150
135
120
105
90
754
739
330
709
694
699
455
674
657
323
313
313323657674455699694709330739754901051201351501651721750000000000000000
       Intangible Assets 
32
28
24
40
35
29
35
28
22
18
15
12
9
6
4
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000012469121518222835293540242832
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000
> Total Liabilities 
1,073
892
1,111
1,332
1,529
2,233
2,017
1,640
1,079
1,268
1,198
2,070
1,339
1,027
1,382
2,675
2,577
2,904
2,735
2,962
3,180
3,616
3,412
4,153
3,592
3,319
3,276
3,248
3,503
2,049
11,852
2,445
2,445
5,373
4,782
4,7825,3732,4452,44511,8522,0493,5033,2483,2763,3193,5924,1533,4123,6163,1802,9622,7352,9042,5772,6751,3821,0271,3392,0701,1981,2681,0791,6402,0172,2331,5291,3321,1118921,073
   > Total Current Liabilities 
482
721
1,019
1,304
1,525
2,227
2,014
1,639
1,078
1,268
1,198
2,070
1,339
1,027
1,382
2,675
2,389
2,727
2,533
2,780
3,001
3,438
3,240
3,990
3,516
3,239
3,276
3,082
3,336
1,870
4,842
2,259
5,429
5,330
4,782
4,7825,3305,4292,2594,8421,8703,3363,0823,2763,2393,5163,9903,2403,4383,0012,7802,5332,7272,3892,6751,3821,0271,3392,0701,1981,2681,0781,6392,0142,2271,5251,3041,019721482
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
441
473
503
0
0
0
0
0
0
0
110
0
0
0
146
0
0
160
0
01600014600011000000005034734410000000000000000
       Accounts payable 
0
0
0
1,271
0
1,829
1,891
1,478
910
1,116
1,084
1,745
1,128
751
1,086
2,011
1,566
1,965
1,645
2,219
2,510
2,895
2,782
3,269
2,943
2,691
291
2,784
2,998
1,722
1,635
2,207
1,283
3,153
3,084
3,0843,1531,2832,2071,6351,7222,9982,7842912,6912,9433,2692,7822,8952,5102,2191,6451,9651,5662,0111,0867511,1281,7451,0841,1169101,4781,8911,82901,271000
       Other Current Liabilities 
482
721
1,019
33
1,525
398
123
160
168
152
113
325
211
277
296
664
382
289
385
561
491
543
458
721
573
548
2,875
298
338
148
3,061
52
4,146
2,017
0
02,0174,146523,0611483382982,8755485737214585434915613852893826642962772113251131521681601233981,525331,019721482
   > Long-term Liabilities 
590
171
92
28
4
5
3
1
1
0
0
0
0
0
0
0
188
177
202
182
179
178
172
163
76
80
0
166
167
179
7,010
186
24,451
43
0
04324,4511867,010179167166080761631721781791822021771880000000113542892171590
> Total Stockholder Equity
3,974
2,702
1,230
6,579
12,919
9,984
7,660
5,435
3,671
2,769
1,259
1,968
7,025
5,481
3,720
263
20,554
17,585
16,118
10,581
19,163
14,102
9,386
11,795
9,618
6,598
7,165
731
-2,026
-164
-6,066
3,757
1,695
14,594
9,856
9,85614,5941,6953,757-6,066-164-2,0267317,1656,5989,61811,7959,38614,10219,16310,58116,11817,58520,5542633,7205,4817,0251,9681,2592,7693,6715,4357,6609,98412,9196,5791,2302,7023,974
   Common Stock
11
11
12
15
23
23
23
23
23
26
3
4
11
11
11
11
24
25
32
33
48
49
49
66
81
2
7
2
2
10
7
55
8
42
0
0428557102272816649494833322524111111114326232323232315121111
   Retained Earnings -117,791-111,125-162,052-159,876-93,317-155,537-154,512-151,375-77,867-144,772-141,316-136,356-130,908-125,550-119,655-111,225-104,489-97,846-92,427-69,721-65,894-63,933-62,188-60,578-57,989-56,299-54,471-52,441-50,028-47,046-43,829-41,118-38,402-36,321-34,838
   Accumulated Other Comprehensive Income 
1,705
1,705
1,640
4,592
7,343
7,343
7,500
8,251
8,281
6,068
6,076
6,609
8,300
8,335
8,404
8,546
21
21
21
21
21
21
21
21
21
21
21
21
21
21
0
21
21
0
0
002121021212121212121212121212121218,5468,4048,3358,3006,6096,0766,0688,2818,2517,5007,3437,3434,5921,6401,7051,705
   Capital Surplus 00000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 
30,523
30,821
31,511
36,665
42,956
43,239
43,740
43,178
43,412
46,828
47,022
50,955
56,098
56,264
56,395
56,624
89,777
93,551
100,828
106,821
125,074
126,781
127,670
135,510
138,278
140,571
84,996
141,438
141,855
145,090
87,236
153,305
163,439
125,398
0
0125,398163,439153,30587,236145,090141,855141,43884,996140,571138,278135,510127,670126,781125,074106,821100,82893,55189,77756,62456,39556,26456,09850,95547,02246,82843,41243,17843,74043,23942,95636,66531,51130,82130,523



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-29,765
Operating Income-29,765-29,765
 
Operating Expense (+$)
Research Development9,402
Selling General Administrative4,145
Selling And Marketing Expenses0
Operating Expense29,76513,547
 
Net Interest Income (+$)
Interest Income90
Interest Expense-19
Other Finance Cost-0
Net Interest Income71
 
Pretax Income (+$)
Operating Income-29,765
Net Interest Income71
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-29,317-30,213
EBIT - interestExpense = -29,317
-29,317
-29,298
Interest Expense19
Earnings Before Interest and Taxes (EBIT)-29,298-29,298
Earnings Before Interest and Taxes (EBITDA)-29,121
 
After tax Income (+$)
Income Before Tax-29,317
Tax Provision-0
Net Income From Continuing Ops-29,317-29,317
Net Income-29,317
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses29,765
Total Other Income/Expenses Net448-71
 

Technical Analysis of TuHURA Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of TuHURA Biosciences Inc. The general trend of TuHURA Biosciences Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine TuHURA Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. TuHURA Biosciences Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of TuHURA Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.77 < 2.8 < 3.43.

The bearish price targets are: 2.1 > 2.1 > 1.8.

Know someone who trades $HURA? Share this with them.πŸ‘‡

TuHURA Biosciences Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of TuHURA Biosciences Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

TuHURA Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of TuHURA Biosciences Inc. The current macd is -0.15288699.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the TuHURA Biosciences Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for TuHURA Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the TuHURA Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
TuHURA Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartTuHURA Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of TuHURA Biosciences Inc. The current adx is 23.56.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell TuHURA Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
TuHURA Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of TuHURA Biosciences Inc. The current sar is 2.22146368.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
TuHURA Biosciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of TuHURA Biosciences Inc. The current rsi is 39.21. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
TuHURA Biosciences Inc Daily Relative Strength Index (RSI) ChartTuHURA Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of TuHURA Biosciences Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the TuHURA Biosciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
TuHURA Biosciences Inc Daily Stochastic Oscillator ChartTuHURA Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of TuHURA Biosciences Inc. The current cci is -50.74349851.

TuHURA Biosciences Inc Daily Commodity Channel Index (CCI) ChartTuHURA Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of TuHURA Biosciences Inc. The current cmo is -22.32498709.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
TuHURA Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartTuHURA Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of TuHURA Biosciences Inc. The current willr is -70.14925373.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that TuHURA Biosciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
TuHURA Biosciences Inc Daily Williams %R ChartTuHURA Biosciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of TuHURA Biosciences Inc.

TuHURA Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of TuHURA Biosciences Inc. The current atr is 0.2591292.

TuHURA Biosciences Inc Daily Average True Range (ATR) ChartTuHURA Biosciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of TuHURA Biosciences Inc. The current obv is 14,456,654.

TuHURA Biosciences Inc Daily On-Balance Volume (OBV) ChartTuHURA Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of TuHURA Biosciences Inc. The current mfi is 24.38.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
TuHURA Biosciences Inc Daily Money Flow Index (MFI) ChartTuHURA Biosciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for TuHURA Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

TuHURA Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of TuHURA Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.213
Ma 20Greater thanMa 502.448
Ma 50Greater thanMa 1003.027
Ma 100Greater thanMa 2003.140
OpenGreater thanClose2.520
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of TuHURA Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on TuHURA Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about TuHURA Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about TuHURA Biosciences Inc

I send you an email if I find something interesting about TuHURA Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about TuHURA Biosciences Inc.

Receive notifications about TuHURA Biosciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.